Faculty Information - Gono Takahisa

（Last updated : 2022-06-01 14:04:49）

Gono Takahisa
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Rheumatology

Position

■ Published papers

1.	Original article	Clinical Characteristics and Cytokine Profiles of Organizing Pneumonia in Patients with Rheumatoid Arthritis Treated with or without Biologics. 2016/04
2.	Original article	Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan. 2016
3.	Original article	Neurocognitive impairment in corticosteroid-naive patients with active systemic lupus erythematosus: a prospective study 2015/03
4.	Original article	Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies. 2015
5.	Original article	New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: a observational case-series study 2014/11
6.	Original article	Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. 2014/06
7.	Original article	Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis. 2013/05
8.	Original article	Ghrelin attenuates collagen production in lesional fibroblasts from patients with systemic sclerosis. 2013/04
9.	Original article	Association of HLA-DRB10101/0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population 2012/11
10.	Original article	Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. 2012/09
11.	Review article	Anti-MDA5 antibody, ferritin and IL-18 are useful forthe evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. 2012/05
12.	Original article	Risperidone in the treatment of corticosteroid-induced mood disorders, manic/mixed episodes in systemic lupus erythematosus: a case series study 2012/05
13.	Original article	Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up. 2011/06
14.	Original article	Activation of the activin A-ALK-Smad pathway in systemic sclerosis. 2011/05
15.	Original article	Clinical manifestations of neurological involvement in primary Sjögrens syndrome. 2011/04
16.	Original article	Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis/polymyositis 2010/10
17.	Original article	Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease 2010/10
18.	Original article	Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease. 2010/10
19.	Original article	Single nucleotide polymorphisms of CD244 gene predispose to renal and neuropsychiatric manifestations with systemic lupus erythematosus. 2010/10
20.	Original article	Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. 2010/09
21.	Original article	Increased ferritin predicts depelopment and severity of acute interstitial lung disease as complication of dermatomyositis 2010/07
22.	Original article	Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. 2010/07
23.	Original article	Increased HGF and c-Met in muscle tissues of polymyositis and dermatomyositis: benefical role of HGF in muscle regeneration 2010/05
24.	Original article	Increased HGF and c-Met in muscle tissues of polymyositis and dermatomyositis: benefical role of HGF in muscle regeneration 2010/05
25.	Original article	Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome 2009
26.	Original article	Selective expression of MHC class I in the affected muscle of a patient with idiopathic inflammatory myopathy 2009
27.	Case report	Successful treatment for sympathetic storms in a patient with neuro-Behcet's disease 2009
Display 5 items
Display all(27)

■ Academic conference presentation

1.	Analysis Of Relationship Between Clinical Manifestations and Autoantibody Profile In ISN/RPS Class V Lupus Nephritis 2013/10
2.	Pirfenidone and BIBF1120 Suppress Collagen Synthesis In Skin Fibroblast From Patients With Systemic Sclerosis 2013/10
3.	Characteristics of cytokine profiles and prognostic factors in interstitial lung disease with polymyositis/dermatomyositis. 2013/06
4.	line blot assay (LBA), a screening test for autoantibodies in systemic sclerosis (SSc) 2012/11
5.	Ischemic Colitis (IC) Associated with Rheumatic Diseases; A Colonoscopic Study of 23 IC Cases 2011/11
6.	Notch pathway is activated in Systemic Sclerosis (SSc) 2011/11
7.	Urinary λ Free Light Chain Concentration Is Associated with Disease Activity and Response to Treatment in Proliferative Lupus Nephritis 2011/11
8.	Anti-C1q Antibodies Are Associated with Global Activity of Systemic Lupus Erythematosus, but Not Specifically with Nephritis. 2010/11/09
9.	Predominant Suppression of Plasmablasts by Cyclophosphamide in Patients with Systemic Lupus Erythematosus: A Possible Therapeutic Mechanism. 2010/11/09
10.	Association of Low-dose Pulsed Intravenous Cyclophosphamide Therapy and Amenorrhea in 62 patients with Systemic Lupus Erythematosus: A Case-control Study. 2010/11/08
11.	Atorvastatin Attenuates Skin Fibrosis Through the PI3K Pathway 2010/11
12.	Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. 2010/11
13.	Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease. 2010/11
14.	Behcet's Disease Followed by the Complication of Myasthenia Gravis 2010/04/24
15.	Activin-Smad pathway is activated in systemic sclerosis 2009/10
16.	Association Study of a Polymorphism of the CD244 Gene with Susceptibility to Systemic Lipus Erythematosus and with Clinical features 2009/10
17.	Association study of a polymorphism of the CD244 gene with susceptibility to systemic lupus erythematosus and with clinical features 2009/10
18.	Augmentation of IL-21 receptor by Endothelin-1 via Endothelin Receptor B in skin fibroblasts from systemic sclerosis 2009/10
19.	Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study 2009/10
20.	Diagnostic Reliability of Magnetic Resonance Imaging for Central Nervous System Syndromes in Systemic Lupus Erythematosus:A Prospective Cohort Study 2009/10
21.	Increased ferritin predicts development and severity of acute interstitial lung disease as complication of dermatomyositis 2009/10
22.	Proteomic Identification of Several Novel Autoantibodies Associated with Systemic Lupus Erythematosus 2009/10
Display 5 items
Display all(22)